This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
We invest in fast growing sectors that will define our future
Sustainability
We see huge potential for innovation as a driving force behind the transition to a circular economy. Across all sectors, a focus on resource efficiency and implementing circular economy business models will not only lead to a large sustainability impact but will also increase the efficiency of production and provide supply-chain benefits through intelligent waste management.
The energy sector is by default cyclical, and as such there are many examples of market expansion before sudden contraction. However, the current energy price crisis differs from past price surges because of the strong focus on climate change and global warming, and the subsequent global pledge to achieve net-zero emissions of greenhouse gases by 2050.
Life Sciences
EMV Capital is focused on identifying, investing in and growing teams which develop solutions that can make a real difference to the problems faced by healthcare systems.
The Group’s dual access to the US and European healthcare markets uniquely positions it to help companies on either side of the Atlantic maximise their growth opportunities.
EMV Capital’s subsidiaries and portfolio companies that specialise in medical diagnostics and therapeutics benefit from the Group’s ability to support the commercialisation of a product or service and its acceleration to market.
Industrials, Robotics & AI
EMV Capital has long-standing experience in Industrials, Robotics, and AI. The Group has witnessed the technological shockwave that is transforming every sector. By advising, supporting, and creating valuable opportunities, we guide our portfolio companies in developing cutting-edge technologies. Our hands-on approach ensures that these companies not only navigate the complexities of this rapidly evolving landscape but also emerge as leaders in state-of-the-art innovations within the sphere.
Uniquely positioned to play a major role in the impact investment space
EMV Capital is uniquely positioned to play a major role in the environmental, social and corporate governance (“ESG”) and impact investment space, having traditionally been an investor in the core areas of healthcare around major chronic diseases for both therapeutics and diagnostics.
By going through potential portfolio company frameworks, EMV Capital identifies ESG areas that may need improvement. The Group targets research projects and sector specific relationship programmes which provide pre-vetted, high environmental impact deal flow opportunities.
SageTech
Inhalational anaesthetics are potent greenhouse gases (HFCs) whose emissions are not currently enforced under environmental regulations such as the UN’s Montreal Protocol and the EU’s F-gas Regulations because they are essential for medical use. Globally, the environmental impact is 3m tonnes of CO2e p.a.
SageTech has developed a patented process that captures, extracts and purifies inhalational anaesthetic agents. The company is also developing recycling technologies for these treated and purified inhalational anaesthetic gases.
The company’s technology captures exhaled waste anaesthetic gases in canisters attached to the exhaust stream of anaesthetic machines in operating theatres. SageTech is also developing the ability to capture from patients in recovery, thus improving the environment for staff and addressing current concerns that theatre and recovery staff’s exposure to volatile anaesthetic agents may breach Health and Safety Executive safe working environment limits.
Ventive
Ventive designs and manufactures some of the most innovative intelligent building service systems in the UK, with an aim to create comfort without costing the Earth. From ventilation to heating and cooling, their ambitious team has already commercialized a few technologies and is well positioned to address the complexities of the Energy Transition with their new range of all-in-one home energy systems.
Ventive has the ambition to provide a healthy, comfortable and safe indoor environment intelligently and at a reasonable cost, also opening the opportunity to help demand energy management on aggregated scale. Their patented technique of Passive Ventilation with Heat Recovery (PHVR™) delivers 100% fresh air while reducing heat loss by up to 72%.
Q-Bot
Q-Bot provides a fully accredited solution for underfloor insulation with suspended floors, making homes warmer while increasing energy efficiency without the hassle of alternative methods. Its unique solution has benefitted an estimated 6,000 people in the social and private housing market, resulting in significant reduction of cold draughts, heat loss through the floor and uneven temperatures.
Retrofitting existing buildings is essential to reaching net zero in the built environment. Residential homes are responsible for around 25 per cent of the UK’s CO2 emissions. Space heating is the largest single energy use in the UK, and accounts for over half of domestic CO2 emissions. According to Q-Bot’s case study of 100 homes where it installed underfloor insulation, each household cut its annual CO2 emissions by 700kg on average. This is the equivalent greenhouse gas (GHG) emission saving as driving over 1,700 miles in a car – like driving from London to Munich and back again.
